# Materialise N.V. (NASDAQ: MTLS), Leuven, Belgium – FDA Inspections

Source: https://www.keypedia.com/companies/materialise-nv/2a11f5c8-845b-4917-9ac6-c5dbfb216ec6

> Inspection records and compliance data for Materialise N.V. in Leuven. 3 FDA inspections on record, 1 Form 483, last inspected March 13, 2025. Publicly traded as NASDAQ: MTLS.

---

## Details

- Name: Materialise N.V.
- FEI Number: 3003998208
- Address Line 1: Technologielaan 15
- City: Leuven
- Country Name: Belgium
- Address: Technologielaan 15, Leuven, Belgium
- Country: Belgium

## Stock

- Stock ticker: MTLS
- Exchange: NASDAQ
- Share price: $6.59
- Market cap: $389.3M
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1264936 - Materialise N.V. - 2025-03-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2025
- [FDA Inspection 1264936 - Materialise N.V. - 2025-03-13](https://www.keypedia.com/records/fda_inspections/materialise-nv/59574c78-1c2a-41dc-9422-a5538b73845c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2025
- FDA Inspection 1264936 - Materialise N.V. - 2025-03-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2025
- FDA Inspection 1264936 - Materialise N.V. - 2025-03-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2025
- FDA Inspection 1003668 - Materialise N.V. - 2017-02-02 — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2017
- FDA Inspection 1003668 - Materialise N.V. - 2017-02-02 — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2017
- [FDA Inspection 868332 - Materialise N.V. - 2014-02-06](https://www.keypedia.com/records/fda_inspections/materialise-nv/57111e03-201d-4233-83ec-5900976a6592) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 6, 2014

## Related Companies

- [PHYSIOL.S.A](https://www.keypedia.com/companies/physiolsa/46086999-0205-4ebb-9c90-b713c610e0d2)
- [HistoGeneX](https://www.keypedia.com/companies/histogenex/99ac74af-fc42-4dfc-9f02-37709f02662a)
- [Medibo N.V.](https://www.keypedia.com/companies/medibo-nv/25ec7dd3-be8c-43c1-b1f4-9ea61c02e93d)
- [Cochlear Technology Centre Belgium](https://www.keypedia.com/companies/cochlear-technology-centre-belgium/0853163a-83e0-4961-b96c-348ee03c72a7)
- [Gynetics Medical Products NV](https://www.keypedia.com/companies/gynetics-medical-products-nv/e1d3effd-259d-4ffa-b7e9-9164d011491b)
- [Agfa Healthcare NV](https://www.keypedia.com/companies/agfa-healthcare-nv/f8fea4ec-092f-48e8-934d-69423fdeed7c)
- [DiaSource ImmunoAssays, SA](https://www.keypedia.com/companies/diasource-immunoassays-sa/50aeb3be-4728-4b7e-b2ff-f57142a22f47)
- [Frederic E. Martens, MD](https://www.keypedia.com/companies/frederic-e-martens-md/9cc30d7f-26f2-42fe-a361-a6719cb29574)
- [Janssens, Luc](https://www.keypedia.com/companies/janssens-luc/ae5819ce-84c3-4d5c-95e5-ef07a2dd0407)
- [Biocartis Nv](https://www.keypedia.com/companies/biocartis-nv/86275d3f-87f4-4444-99cd-2d07069cd584)